Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Buy

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Virax Biolabs Group Limited Ordinary Shares (VRAX)

https://www.viraxbiolabs.com

Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/21/2022

Market Cap

4,463,760

Shares Outstanding

1,810,000

Weighted SO

1,811,539

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.5560

Last Div

0.0000

Range

0.6-4.0

Chg

0.4999

Avg Vol

1604591

Mkt Cap

4463760

Exch

NASDAQ

Country

GB

Phone

44 20 7788 7414

DCF Diff

0.2159

DCF

0.8051

Div Yield

0.0000

P/S

56.2888

EV Multiple

0.0662

P/FV

0.5298

Div Yield %

0.0000

P/E

-0.4846

PEG

0.0020

Payout

0.0000

Current Ratio

7.5870

Quick Ratio

7.5559

Cash Ratio

6.4901

DSO

843.9587

DIO

127.3079

Op Cycle

971.2666

DPO

2122.5800

CCC

-1151.3134

Gross Margin

0.1139

Op Margin

-88.2512

Pretax Margin

-87.2395

Net Margin

-87.3070

Eff Tax Rate

0.6196

ROA

-0.9855

ROE

-0.8957

ROCE

-1.1219

NI/EBT

1.0008

EBT/EBIT

0.9885

EBIT/Rev

-88.2512

Debt Ratio

0.0259

D/E

0.0287

LT Debt/Cap

0.0204

Total Debt/Cap

0.0279

Int Coverage

-438.1126

CF/Debt

-29.3933

Equity Multi

1.1093

Rec Turnover

0.4325

Pay Turnover

0.1720

Inv Turnover

2.8671

FA Turnover

0.1167

Asset Turnover

0.0113

OCF/Share

-3.0085

FCF/Share

-3.5079

Cash/Share

2.9322

OCF/Sales

-67.3501

FCF/OCF

1.1660

CF Coverage

-29.3933

ST Coverage

-107.5088

CapEx Coverage

-6.0242

Div&CapEx Cov

-6.0242

P/BV

0.5298

P/B

0.5298

P/S

56.2888

P/E

-0.4846

P/FCF

-0.7168

P/OCF

-0.6282

P/CF

-0.6282

PEG

0.0020

P/S

56.2888

EV Multiple

0.0662

P/FV

0.5298

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation